Breaking News Instant updates and real-time market news.

SODA

Acquired by PEP

$129.89

1.12 (0.87%)

, PEP

PepsiCo

$114.98

0.7 (0.61%)

09:14
08/20/18
08/20
09:14
08/20/18
09:14

Fly Intel: Pre-market Movers

HIGHER: SodaStream (SODA), up 10% after PepsiCo (PEP) agreed to acquire SodaStream for $144 per share in cash... MiX Telematics (MIXT), up 7% after being upgraded to strong buy from outperform at Raymond James... Nike (NKE), up 2% after Susquehanna analyst Sam Poser upgraded Nike to Positive from Neutral and Piper Jaffray analyst Erinn Murphy upgraded Nike to Overweight from Neutral... Black Box (BBOX), up 17% after announcing that it has entered into a definitive agreement to sell its Federal Government IT Services Business to a private equity firm for a cash purchase price of $75M. LOWER: Lannett (LCI), down 52% after reporting preliminary Q4 earnings... Tesla (TSLA), down 5% after Reuters reported that Saudi Arabia's PIF is in talks to invest in an aspiring Tesla rival and after JPMorgan analyst Ryan Brinkman reduced his price target on the stock back to $195 from $308... Infosys (INFY), down 3% after being downgraded to Equal Weight from Overweight at Morgan Stanley.... Constellation Brands (STZ), down 2% after Susquehanna analyst Pablo Zuanic downgraded the stock to Negative from Neutral.... News Corp. (NWSA) down 3% after Morgan Stanley analyst Andrew McLeod downgraded the stock to Underweight from Equal Weight.

SODA

Acquired by PEP

$129.89

1.12 (0.87%)

PEP

PepsiCo

$114.98

0.7 (0.61%)

TSLA

Tesla

$305.33

-30.13 (-8.98%)

MIXT

MiX Telematics

$15.09

-0.17 (-1.11%)

NKE

Nike

$79.73

-0.32 (-0.40%)

BBOX

Black Box

$1.64

0.09 (5.81%)

LCI

Lannett

$13.50

-0.25 (-1.82%)

INFY

Infosys

$21.09

0.095 (0.45%)

STZ

Constellation Brands

$203.90

1.47 (0.73%)

NWS

News Corp

$14.40

0.1 (0.70%)

  • 20

    Aug

  • 28

    Aug

  • 12

    Sep

  • 02

    Oct

  • 28

    Oct

  • 29

    Oct

SODA Acquired by PEP
$129.89

1.12 (0.87%)

09/25/17
SUSQ
09/25/17
NO CHANGE
Target $90
SUSQ
Positive
SodaStream price target raised to $90 from $79 at Susquehanna
Susquehanna analyst Pablo Zuanic raised his price target on SodaStream to $90 from $79 after meetings with the company, during which it said it is adding about 1M households per year to its platform. He said those numbers could prove to be conservative given its plans to triple its penetration in Germany and a reinvigorated push in the U.S. He sees improved economics, including higher machine margins, lower customer acquisition costs, new plant efficiencies, and improved EBIT. Zuanic reiterated his Positive rating on SodaStream shares.
04/03/18
RILY
04/03/18
INITIATION
Target $110
RILY
Buy
SodaStream initiated with a Buy at B. Riley FBR
B. Riley FBR analyst Jeff Van Sinderen started SodaStream with a Buy rating and $110 price target. The analyst sees growth opportunities both in the U.S. and abroad.
04/04/18
04/04/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. AT&T (T) initiated with a Buy at Spin-Off Research. 2. Spotify (SPOT) initiated with a Hold at Gabelli. 3. Wix.com (WIX) initiated with an Outperform at William Blair. 4. SodaStream (SODA) initiated with a Buy at B. Riley FBR. 5. Booking Holdings (BKNG) initiated with an Outperform at Wedbush while Expedia (EXPE), TripAdvisor (TRIP), and Trivago (TRVG) were initiated with a Neutral. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
PEP PepsiCo
$114.98

0.7 (0.61%)

07/16/18
RBCM
07/16/18
NO CHANGE
Target $75
RBCM
Outperform
Monster Beverage price hike to come November 1st, says RBC Capital
RBC Capital analyst Nik Modi says his industry sources have confirmed that Monster Beverage (MNST) intends to raise its prices by 4.0-5.5% on November 1st depending on the pack size, which would be in line with the management's indication of pricing review made at the June shareholder meeting. The analyst keeps his Outperform rating and $75 price target on Monster, adding that Coca Cola (KO), PepsiCo (PEP) and Keurig Dr Pepper (KDP) will also likely make pricing changes in response over the coming months.
07/23/18
JEFF
07/23/18
NO CHANGE
Target $107
JEFF
Hold
Jefferies sees risk of near-term downside in PepsiCo shares
Jefferies analyst Kevin Grundy sees potential near-term downside in shares of PepsiCo. Despite fundamental challenges and weak earnings quality, PepsiCo's "relative multiple remains elevated," Grundy tells investors in a research note. The analyst is "negatively biased" toward PepsiCo and reiterates a Hold rating on the shares with a $107 price target.
07/24/18
RHCO
07/24/18
NO CHANGE
Target $110
RHCO
Hold
PepsiCo price target raised to $110 from $105 at SunTrust
SunTrust analyst William Chappell raised his price target on PepsiCo to $110 to account for gains related to the impact of refranchising transactions, which he expects to support the company's high-single-digit EPS growth trend going forward. The analyst also keeps his Hold rating on PepsiCo as the stock is "fairly valued", with the company's Beverage business trading in line with peers and the Food business trading at the high end of its large-cap snack food peer range.
08/14/18
EVER
08/14/18
NO CHANGE
EVER
BodyArmor stake positive for Coca-Cola, negative for Pepsi, says Evercore
Evercore ISI analyst Robert Ottenstein views Coca-Cola's stake in BodyArmor as a "clear positive" for the company and a "clear negative" for both PepsiCo (PEP) and Keurig Dr Pepper (KDP). Pepsi's Gatorade product is most at risk with Coca-Cola taking a stake in BodyArmor, and Keurig Dr Pepper "losses distribution of the product and any path to ownership it might have enjoyed," Ottenstein tells investors in a research note.
TSLA Tesla
$305.33

-30.13 (-8.98%)

08/15/18
VERT
08/15/18
NO CHANGE
VERT
Sell
Goldman involvement with Tesla 'doesn't mean anything,' says Vertical Research
Vertical Research analyst Gordon Johnson said Goldman Sachs (GS) being confirmed as a financial advisor to Tesla's (TSLA) proposed go-private offer "does not mean anything" beyond the "superficial optics" of the carmaker being able to "use Goldman's prestigious name to lend credence to the deal." Goldman is "in it for M&A fees" and agreeing to be an advisor is "not based on any inherent understanding of Tesla's value proposition, nor is it based on Goldman's confidence in Tesla's legal situation with respect to its significant issues surrounding disclosures and SEC involvement," according to Johnson, who maintains a Sell rating on Tesla shares.
08/16/18
BERN
08/16/18
NO CHANGE
Target $325
BERN
Tesla price target raised to $325 after 'taking company private' tweet at Bernstein
Bernstein analyst A.M. Sacconaghi, Jr. raised his price target for Tesla to $325 after Elon Musk shocked investors last week when he tweeted that he was considering a take-private transaction for Tesla at $420 per share, and given the fact that it has been over a year since the analyst last adjusted his price target. Sacconaghi sees the odds of a successful take-private transaction at less than 50%, with downside to about $300 and upside to approximately $400.
08/16/18
EVER
08/16/18
NO CHANGE
Target $301
EVER
In Line
After visiting Tesla's Freemont facility, Evercore ISI says Model 3 'on track'
Evercore ISI analyst George Galliers said he is a bit more positive on Tesla following his trip to the company's Freemont facility, stating that Tesla "seems well on the way" to achieving steady production of 5,000 to 6,000 Model 3 units per week and that reaching 7,000 to 8,000 units per week seems "well within reach." Following the trip, he said the Model 3 looks to be "on track" and while he continues to forecast second half Model 3 production of 123,000 units, Galliers now believes his estimate could be 4%-7% too low. He maintains an In Line rating on Tesla shares with a $301 price target.
MIXT MiX Telematics
$15.09

-0.17 (-1.11%)

08/20/18
RAJA
08/20/18
UPGRADE
RAJA
Strong Buy
MiX Telematics upgraded to Strong Buy from Outperform at Raymond James
NKE Nike
$79.73

-0.32 (-0.40%)

08/16/18
08/16/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. ARGUS SAYS BUY LULULEMON: Argus analyst John Staszak upgraded Lululemon (LULU) to Buy from Hold with a price target of $150, citing the company's Q1 earnings beat and expectations of improved comps in Q2, along with its "substantial" growth opportunities to expand its brand overseas and particularly in China. Staszak contends that Lululemon's growth prospects are "among the best in the apparel sector," with a transition to higher margin e-commerce sales seen expanding its operating margins in the coming several years. The analyst further notes that his implied price target valuation multiple of 44-times forward earnings is within the multiple range of companies like Nike (NKE), Under Armour (UA), and VF Corp. (VFC) and justified by its rapid e-commerce adoption and strong overall growth. KIMBERLY-CLARK RAISED AFTER PRICE HIKES: JPMorgan analyst Andrea Teixeira upgraded shares of Kimberly-Clark (KMB) to Neutral from Underweight and raised her price target to $114 from $90 following yesterday's announcement that the company will increase prices or reduce package counts on key products in North America. The analyst notes that while it remains to be seen if the price increases will "actually hold" given the intensely competitive U.S. market, she believes investors will give Kimberly-Clark shares the benefit of the doubt. Additionally, she tells investors that Procter & Gamble's (PG) commentary that it plans to raise prices on some of its premium paper products and diapers is "supportive" of Kimberly-Clark's ability to pass on higher prices. COTY CUT TWO NOTCHES AT MERRILL: BofA Merrill Lynch analyst Olivia Tong double downgraded Coty to Underperform from Buy and cut its price target to $10 from $16. Tong said Coty is now more exposed to the mass beauty market following its merger with 41 brands from PG Beauty and is seeing disruption from smaller, niche brands and newer distribution channels. ACTIVISION PULLBACK SEEN AS OPPORTUNITY: Jefferies analyst Timothy O'Shea said he views China having frozen mobile game approvals as a temporary problem and "mostly a non-issue" as only the monetization approval process has been frozen, not the content approval process, and he notes administrators are already implementing a fast-track approval process to alleviate the problem. Activision Blizzard (ATVI) has a pipeline of new mobile games coming that he would still expect to launch in China over time and O'Shea sees the 15% pullback in the game maker's shares in the last month as a buying opportunity, he tells investors. He maintains a Buy rating and $90 price target on Activision shares.
08/20/18
SUSQ
08/20/18
UPGRADE
Target $93
SUSQ
Positive
Nike upgraded to Positive at Susquehanna
As reported previously, Susquehanna analyst Sam Poser upgraded Nike to Positive from Neutral. The analyst cited its market share gains and gains within the family footwear channel. The gains are due to improved product offerings and product flow, putting the company on pace to meet its 2023 $50B revenue target, said Poser. He raised his price target to $93 from $78 on Nike shares.
08/20/18
SUSQ
08/20/18
UPGRADE
SUSQ
Positive
Nike upgraded to Positive from Neutral at Susquehanna
08/20/18
PIPR
08/20/18
UPGRADE
Target $93
PIPR
Overweight
Nike upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Erinn Murphy upgraded Nike to Overweight from Neutral and raised her price target for shares to $93 from $72, telling investors in a research note that she believes the risk profile of owning Nike shares has "considerably diminished" and sees Nike moving from downward EPS revisions to upward revisions supported by a stabilizing North America landscape, strong margin and sales drivers and improving brand momentum. Murphy sees EPS power for 2023 to greater than $5.60/share amid the "extremely healthy" athletic category.
BBOX Black Box
$1.64

0.09 (5.81%)

LCI Lannett
$13.50

-0.25 (-1.82%)

08/24/17
CHLM
08/24/17
NO CHANGE
Target $32
CHLM
Buy
Craig-Hallum remains a buyer of Lannett
Craig-Hallum analyst Matt Hewitt says that while the sector continues to be under pressure with terms like "price erosion" and "increased competition" heard with more frequency to describe market dynamics, he continues to believe Lannett stock is undervalued. Despite a plethora of initiatives to drive growth and increasing cost synergies being realized from the Kremers Urban acquisition, the company trades at a "significant" discount to peers, he argues. Hewitt reiterates a Buy rating and $32 price target on the shares.
01/24/18
GSCO
01/24/18
INITIATION
Target $21
GSCO
Neutral
Lannett initiated with a Neutral at Goldman Sachs
Goldman analyst Dana Flanders initiated Lannett with a Neutral and $21 price target.
06/18/18
DBAB
06/18/18
NO CHANGE
DBAB
Lannett falls after Deutsche Bank addresses 'elephant in the room'
Shares of Lannett after falling after Deutsche Bank analyst Gregg Gilbert told investors to brace for "significant volatility" on the upcoming levothyroxine outcome. The "elephant in the room" is that depending on ongoing negotiations with Lannett's partner Jerome Stevens Pharmaceuticals, the company's largest product levothyroxine, which represented 34% of sales in fiscal 2018, could go away in March 2019, Gilbert wrote earlier in a research note. The product, however, could remain part of the Lannett portfolio for years to come if the partnership term is extended, the analyst added. Gilbert predicts the stock "could crumble" if the agreement is not extended. On the flip side, the shares could spike as "shorts are squeezed" if Lannett were to reach a new deal with Jerome Stevens, Gilbert says. He expects to see this situation "come to a head" over the next two months. Lannett's new CEO Tim Crew has a sense of urgency to get this done, Gilbert believes. The analyst sees the most likely outcome as an extension to the agreement, "perhaps at some additional cost" to Lannett. Such an outcome "could help the shares move higher in the short term, and set the stage for interesting strategic options longer term," Gilbert explains. He keeps a Hold rating on Lannett. The stock in morning trading is down 6%, or $1.00, to $14.90.
INFY Infosys
$21.09

0.095 (0.45%)

07/12/18
DBAB
07/12/18
INITIATION
DBAB
Buy
Infosys initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Srinivas Roa started Infosys with a Buy rating and INR 1,495 price target. The analyst sees currency tailwinds helping the company's financials in fiscal 2019.
08/20/18
MSCO
08/20/18
DOWNGRADE
MSCO
Equal Weight
Infosys downgraded to Equal Weight from Overweight at Morgan Stanley
04/06/18
BREN
04/06/18
INITIATION
Target $14
BREN
Sell
Infosys initiated with a Sell at Berenberg
Berenberg analyst Georgio Kertsos initiated Infosys with a Sell and $14 price target citing deteriorating growth and margins due to historically low levels of investment. Kertsos expects pricing pressure to accelerate and for wage inflation to increasingly challenge profitability.
04/13/18
BREN
04/13/18
NO CHANGE
Target $14
BREN
Sell
Infosys deteriorating profitability remains underappreciated, says Berenberg
After Infosys reported Q4 results that were in-line with consensus expectations and trimmed its FY19 EBIT margin guidance, Berenberg analyst Georgios Kertsos said he continues to think the market underappreciates that the company's growth is coming at the expense of profitability. The analyst, who believes the pricing pressure the company faces will persist, maintains a Sell rating on Infosys shares.
STZ Constellation Brands
$203.90

1.47 (0.73%)

08/20/18
SUSQ
08/20/18
DOWNGRADE
SUSQ
Negative
Constellation Brands downgraded to Negative from Neutral at Susquehanna
08/16/18
DBAB
08/16/18
NO CHANGE
Target $226
DBAB
Buy
Constellation Brands price target lowered to $226 from $234 at Deutsche Bank
Deutsche Bank analyst Steve Powers lowered his price target for Constellation Brands (STZ) to $226 from $234, telling investors in a research note that yesterday's Canopy Growth (CGC) transaction "caught us off guard, incrementally testing our conviction in a name in which we already had reservations exiting Q1 results." Going forward, the analyst expects Constellation to remain under near-term pressure as investors assess the merits of the cannabis business and struggle with the opportunity costs of chasing it, placing incremental importance on near-term beer/wine/spirits results. Powers maintains a Buy rating.
08/16/18
ADAM
08/16/18
UPGRADE
ADAM
Speculative Buy
Canopy Growth upgraded to Speculative Buy at Canaccord
As reported previously, Canaccord analyst Matt Bottomley upgraded Canopy Growth (CGC) to Speculative Buy from Hold. The analyst believes its deal with Constellation Brands (STZ) is transformational for the company and for the industry as a whole in that the deal represents a commitment from an established, international partner that is a top tier producer/distributor of alcohol worldwide. Bottomley raised his price target to C$50 from C$34 on Canopy Growth shares.
08/20/18
SUSQ
08/20/18
DOWNGRADE
Target $171
SUSQ
Negative
Constellation Brands downgraded to Negative at Susquehanna
As reported previously, Susquehanna analyst Pablo Zuanic downgraded Constellation Brands to Negative from Neutral. The analyst lowered his estimates and rating based on valuation when measured against comps and slower growth. Zuanic lowered his price target to $171 from $199 on Constellation Brands shares.
NWS News Corp
$14.40

0.1 (0.70%)

08/20/18
08/20/18
DOWNGRADE
Target $12.5

Underweight
News Corp. downgraded to Underweight on Foxtel OTT risks at Morgan Stanley
As previously reported, Morgan Stanley analyst Andrew McLeod downgraded News Corp. to Underweight from Equal Weight, noting that its Australian payTV unit, Foxtel, will launch a new OTT sports service by the end of 2018, which presents the "obvious risk" that its existing subscriber base and high ARPU will come under pressure. While McLeod believes it's a risk that should be taken because "history says that if Foxtel doesn't disrupt itself, someone else will," he also cut his estimates and value for the unit. McLeod lowered his price target on News Corp. shares to $12.50 from $17.00.

TODAY'S FREE FLY STORIES

03:30
05/27/19
05/27
03:30
05/27/19
03:30
General news
FX Action: USD-CAD has settled in the mid 1.3400s »

FX Action: USD-CAD has…

03:00
05/27/19
05/27
03:00
05/27/19
03:00
General news
FX Update: Risk-off positioning have unwound some more in the forex markets »

FX Update: Risk-off…

02:35
05/27/19
05/27
02:35
05/27/19
02:35
General news
Asian Market Wrap: »

Asian Market Wrap:…

TEVA

Teva

$10.86

-0.18 (-1.63%)

12:11
05/26/19
05/26
12:11
05/26/19
12:11
Hot Stocks
Teva reaches $85M agreement with State of Oklahoma »

Teva Pharmaceuticals USA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESLT

Elbit Systems

$141.85

1.33 (0.95%)

12:08
05/26/19
05/26
12:08
05/26/19
12:08
Hot Stocks
Elbit Systems awarded $127M contract to provide tactical radio system »

Elbit Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

ADM

Archer Daniels

$39.17

-0.03 (-0.08%)

12:05
05/26/19
05/26
12:05
05/26/19
12:05
Hot Stocks
Archer Daniels expands recall of Baker's Corner All Purpose Flour 5lb bags »

ADM Milling is recalling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

JCP

J.C. Penney

$0.93

0.022 (2.42%)

, DDS

Dillard's

$56.57

0.25 (0.44%)

13:29
05/25/19
05/25
13:29
05/25/19
13:29
Periodicals
Target stock triumphs in brutal week for retail, Barron's says »

Earnings season has been…

JCP

J.C. Penney

$0.93

0.022 (2.42%)

DDS

Dillard's

$56.57

0.25 (0.44%)

KSS

Kohl's

$51.11

-0.04 (-0.08%)

JWN

Nordstrom

$33.50

-0.31 (-0.92%)

M

Macy's

$21.00

-0.27 (-1.27%)

TGT

Target

$81.57

2.17 (2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

JPM

JPMorgan

$109.78

1.14 (1.05%)

, AKZOY

AkzoNobel

$0.00

(0.00%)

13:24
05/25/19
05/25
13:24
05/25/19
13:24
Periodicals
Microsoft, JPMorgan among dividend champions, Barron's says »

Among the companies that…

JPM

JPMorgan

$109.78

1.14 (1.05%)

AKZOY

AkzoNobel

$0.00

(0.00%)

XOM

Exxon Mobil

$74.12

0.33 (0.45%)

MSFT

Microsoft

$126.23

0.04 (0.03%)

CMWAY

Commonwealth Bank of Australia

$0.00

(0.00%)

SIEGY

Siemens

$0.00

(0.00%)

T

AT&T

$32.29

0.15 (0.47%)

RDS.A

Royal Dutch Shell

$63.29

0.84 (1.35%)

RHHBY

Roche

$0.00

(0.00%)

NVS

Novartis

$87.49

3.03 (3.59%)

BHP

BHP Group

$52.47

1.18 (2.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 29

    May

  • 29

    May

  • 31

    May

  • 03

    Jun

  • 03

    Jun

  • 03

    Jun

  • 05

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 11

    Jun

  • 12

    Jun

  • 20

    Jun

  • 23

    Jun

  • 16

    Jul

  • 24

    Jul

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 02

    Sep

  • 04

    Nov

GM

General Motors

$35.13

0.01 (0.03%)

, TSLA

Tesla

$190.80

-4.7 (-2.40%)

13:19
05/25/19
05/25
13:19
05/25/19
13:19
Periodicals
Tesla stock in trouble, Barron's says »

Tesla (TSLA) stock is the…

GM

General Motors

$35.13

0.01 (0.03%)

TSLA

Tesla

$190.80

-4.7 (-2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 05

    Jun

  • 11

    Jun

  • 01

    Aug

RNLSY

Renault

$0.00

(0.00%)

13:14
05/25/19
05/25
13:14
05/25/19
13:14
Periodicals
Renault stock may rally, Barron's says »

Shares of French auto…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FMC

FMC Corporation

$70.88

-0.47 (-0.66%)

, DWDP

DowDuPont

$31.10

0.16 (0.52%)

13:11
05/25/19
05/25
13:11
05/25/19
13:11
Periodicals
DowDuPont spinoff a new agriculture stock, FMC safer bet, Barron's says »

The crop-protection and…

FMC

FMC Corporation

$70.88

-0.47 (-0.66%)

DWDP

DowDuPont

$31.10

0.16 (0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 25

    Jun

MGM

MGM Resorts

$25.55

0.19 (0.75%)

13:03
05/25/19
05/25
13:03
05/25/19
13:03
Periodicals
MGM Resorts looks like an attractive gambling play, Barron's says »

MGM Resorts (MGM) stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

PYPL

PayPal

$109.82

-0.09 (-0.08%)

, AXP

American Express

$119.52

1.07 (0.90%)

12:30
05/25/19
05/25
12:30
05/25/19
12:30
Periodicals
Big tech failed to dethrone credit cards, Barron's says »

Rather than being cut out…

PYPL

PayPal

$109.82

-0.09 (-0.08%)

AXP

American Express

$119.52

1.07 (0.90%)

MA

MasterCard

$251.40

1.57 (0.63%)

V

Visa

$162.72

1.2 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 03

    Jun

  • 05

    Jun

  • 06

    Jun

  • 11

    Jun

  • 25

    Jun

  • 13

    Nov

GOOG

Alphabet

$1,132.99

-7.56 (-0.66%)

, GOOGL

Alphabet Class A

$1,138.90

-5.98 (-0.52%)

07:20
05/25/19
05/25
07:20
05/25/19
07:20
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

GOOG

Alphabet

$1,132.99

-7.56 (-0.66%)

GOOGL

Alphabet Class A

$1,138.90

-5.98 (-0.52%)

MSFT

Microsoft

$126.23

0.04 (0.03%)

AMBA

Ambarella

$38.28

1.07 (2.88%)

ON

ON Semiconductor

$17.68

-0.235 (-1.31%)

NKE

Nike

$82.12

-0.51 (-0.62%)

ADDYY

Adidas

$0.00

(0.00%)

UAA

Under Armour

$23.54

0.075 (0.32%)

UA

Under Armour

$20.91

0.08 (0.38%)

FL

Foot Locker

$44.39

-8.455 (-16.00%)

VMC

Vulcan Materials

$126.28

1.25 (1.00%)

FLR

Fluor

$29.04

0.18 (0.62%)

ACM

Aecom

$31.56

-0.03 (-0.09%)

X

U.S. Steel

$13.63

-0.08 (-0.58%)

AKS

AK Steel

$2.00

-0.155 (-7.21%)

NUE

Nucor

$51.12

-0.27 (-0.53%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$12.85

0.11 (0.86%)

F

Ford

$9.83

-0.02 (-0.20%)

GM

General Motors

$35.13

0.01 (0.03%)

HMC

Honda

$25.45

0.175 (0.69%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$118.54

1.16 (0.99%)

VWAGY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 03

    Jun

  • 03

    Jun

  • 04

    Jun

  • 04

    Jun

  • 05

    Jun

  • 06

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Jun

  • 19

    Jun

  • 19

    Jun

  • 23

    Jun

  • 09

    Jul

  • 24

    Jul

  • 31

    Jul

  • 01

    Aug

  • 06

    Aug

  • 23

    Oct

  • 27

    Oct

UBER

Uber

$41.40

0.94 (2.32%)

17:49
05/24/19
05/24
17:49
05/24/19
17:49
Hot Stocks
Uber board director Ryan Graves intends to resign »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

APTO

Aptose Biosciences

$2.01

0.03 (1.52%)

17:46
05/24/19
05/24
17:46
05/24/19
17:46
Syndicate
Aptose Biosciences files for $40M at-the-market common stock offering »

Piper Jaffray and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TRNX

Taronis Technologies

$0.48

0.004 (0.84%)

17:26
05/24/19
05/24
17:26
05/24/19
17:26
Syndicate
Breaking Syndicate news story on Taronis Technologies »

Taronis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:25
05/24/19
05/24
17:25
05/24/19
17:25
Hot Stocks
U.S. Energy discloses Nasdaq notice regarding delayed 10-Q filing »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

17:22
05/24/19
05/24
17:22
05/24/19
17:22
Periodicals
Apple sued over allegedly selling users' iTunes data, Bloomberg says »

Apple is being sued by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SPCB

SuperCom

$1.17

-0.005 (-0.43%)

17:21
05/24/19
05/24
17:21
05/24/19
17:21
Hot Stocks
SuperCom discloses Nasdaq notice regarding delayed 20-F filing »

SuperCom received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:20
05/24/19
05/24
17:20
05/24/19
17:20
Hot Stocks
U.S. Energy receives noncompliance notice from Nasdaq »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:18
05/24/19
05/24
17:18
05/24/19
17:18
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:17
05/24/19
05/24
17:17
05/24/19
17:17
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$87.49

3.03 (3.59%)

, QGEN

Qiagen

$38.22

-0.255 (-0.66%)

16:57
05/24/19
05/24
16:57
05/24/19
16:57
Hot Stocks
Qiagen launches diagnostic for PIK3CA biomarkers in breast cancer »

Qiagen (QGEN) announced…

NVS

Novartis

$87.49

3.03 (3.59%)

QGEN

Qiagen

$38.22

-0.255 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

  • 20

    Jun

  • 06

    Aug

AVH

Avianca

$3.96

0.91 (29.84%)

16:56
05/24/19
05/24
16:56
05/24/19
16:56
Periodicals
ANAC suspends flights, operations of Avianca Brasil, Reuters reports »

Brazil's ANAC said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.